Florastina Payton-Stewart PhD

Florastina Payton-Stewart PhD

Assistant Professor

The Payton-Stewart research projects involves the design, synthesis, characterization, and biological screening of novel anti-canceragents.

Dr. Payton-Stewart's  research involvesunderstanding the molecular mechanism and biological activity of naturally occurring plant phytoalexins and their analogs as     they pertain to breast carcinomas. One major focus of the Payton-Stewart research laboratory is to identify the structural activity relationship(SAR) of synthesize analogs.  This research laboratory designs anti-cancer agents for various forms of cancer such prostate, triple negative breast cancer, endocrine resistant breast cancer and lung cancer.

ORCID Identifier: 0000-0002-0677-8150

Key Words:

Drug Design

Cancer

Therapeutic Agents

Structural Activity Relationship

Breast Cancer

Phytoalexins

SELECTED PUBLICATIONS

Walker,Rashida R; Patel, Jankiben, R.; Gupta, Akash; Davidson, Michael A.; Williams,Christopher, C.; Payton-Stewart, Florastina; Boue, Stephen, M.; Burow,Matthew, E.; Khupse, Rahul; and Tilghman, Syreeta, L.  International Journal of Molecular Sciences2022, 23(5):2887.  DOI: 10.3390/ijms23052887

Wilson-Kennedy,Z.; Winfield, L.; Nielson, J.; Arriaga, E.; Kimble-Hill, A.; Payton-Stewart,F. Introducing the Journal of Chemical Education’s Special Issue onDiversity, Equity, Inclusion, and Respect in Chemistry Education Research andPractice. Journal of Chemical Education 2021.  DOI: 10.1021/acs.jchemed.1c01219.

Payton-Stewart, Florastina LaTaya,Leyte L. Winfield, and Zakiya Wilson-Kennedy. Toward IntentionalDiversity, Equity, and Respect in Chemistry Research and Practice. Journalof Chemical Education 97 (8). ACS Division of Chemical Education and theAmerican Chemical Society Publications division.: 2041–44, 2020. https://pubs.acs.org/doi/10.1021/acs.jchemed.0c00963 

 

Israel, Bridg’ette B.,Tilghman, Syreeta L., Parker-Lemieux, KiTani, and Payton-Stewart, Florastina.  Phytochemicals: Current Strategies forTreating Breast Cancer.  OncologyLetters 15:  7471-7478, 2018. DOI: 10.3892/ol.2018.8304

 

Gong, Jingjing, Munoz,Amanda, Pingali, Subramanya, Payton-Stewart, Florastina, Chan, Daniel,Freeman, James, Ghosh, Rita, Kumar, Addanki Pratap. Downregulation of STAT3/NF-κB potentiatesgemcitabine activity in pancreatic cancer cells.  Molecular Carcinogenesis, 56 (2), 402-411,2017.  DOI: 10.1002/mc.22503

 

Carriere,Patrick, Llopis, D. Shawn, Naiki, Annai, Nguyen, Gina, Phan, Tina, Nguyen, M.Mary, Preyan, C. Lynez, Yearby, Letecia, Pratt, Jamal, Davenport, Ian, Nguyen,A. Thu, Parker-Lemieux, KiTani, Payton-Stewart, Florastina,Williams, C. Christopher, Boue, M. Stephen, Tilghman, L. Syreeta.  Glyceollin I Reverses Epithelial toMesenchymal Transition in Letrozole Resistance Through ZEB1.  International Journal of EnvironmentalResearch and Public Health 13 (1), 10, 2016. DOI: 10.3390/ijerph13010010

 

Toro,Tasha B., Subramanya Pingali, Thao P. Nguyen, De S. Garrett, Kyr A. Dodson, KyA. Nichols, R A. Haynes, Florastina Payton-Stewart, and Terry J. Watt. KDAC8with High Basal Velocity Is Not Activated by N-Acetylthioureas. PloS One 11(1), 2016. https://pubmed.ncbi.nlm.nih.gov/26745872/ 

 

Pingali,S. and Donahue, J.P. and Payton-Stewart, F.  Tetrahydroberberine, a pharmacologicallyactive naturally occurring alkaloid. Acta Crystallographica Section C71, 262-265, 2015. DOI: 10.1107/S2053229615004076

 

Payton-Stewart F,Tilghman SL, Williams LG & Winfield LL. Benzimidazoles diminish ERE

transcriptional activityand cell growth in breast cancer cells. Biochemical andBiophysical

Research Communications,PMID: 24997336, 450, (4), 1358-1362, 2014. DOI:

10.1016/j.bbrc.2014.06.130

 

Pingali, S. and Donahue, J.P. and Payton-Stewart, F.  Weak C-H->X (X = O, N) Hydrogen Bondsin the Crystal Structure of Dihydroberberine.  Acta Crystallographica Section C70,388-391, 2014. DOI: 10.1107/S2053229614003751

 

Payton-Stewart, F.,Pingali, S. and Donahue, J.P.  Thechalcone derivative(E)-1-(4-fluorophenyl)-3-(4-hydroxy-3-methoxyphenyl)prop-2-en-1-onemonohydrate. Acta Crystallographica69E: 558-559, 2013. https://doi.org/10.1107/S160053681300696X

 

Winfield,L.; Payton-Stewart, F.  Celecoxiband Bcl-2: Emerging Possibilities for Anticancer Drug Design. FutureMedicinal Chemistry, 4 (3) 361-383, 2012. DOI: 10.4155/fmc.11.177

 

Payton-Stewart, Florastina,Bose, Rumu, Alworth, William, L., Kumar, Addanki, Ghosh, Rita.  4-methylcatechol-Induced Oxidative Stressin Metastatic Melanoma Cells Leads to Intrinsic Apoptotic Pathway.  Biochemical Pharmacology 81 (10):1211-1218, 2011. doi: 10.1016/j.bcp.2011.03.005

 

Payton-Stewart*, Florastina,Jiang*, Quan, Elliott, Steven, Driver, Jennifer,  Zhang, Qiang,Zheng,  Shilong,  Bhatnagar, Deepak , Boue, M. Stephen,  Wiese, E. Thomas, Burow, E. Matthew, Wang ,Guangdi.   Effects of 7-OSubstitutions on Estrogenic and Anti-Estrogenic Activities of DaidzeinAnalogues in MCF-7 Breast Cancer Cells.  J.Med. Chemistry 53 (16): 6153-6163, 2010. DOI: 10.1016/j.bcp.2011.03.005

 

Payton-Stewart, Florastina,Boue, M. Stephen, Elliott, Steven, Zimmerman, Carla M.,  Skripnikova, Elena V., Ashe, Hasina,Tilghman, Syreeta L., Beckman, Barbara S., McLachlan, John A., Bhatnagar,Deepak, Wiese, Thomas E., Erhardt, Paul, Burow, Matthew E.  Glyceollin I enantiomers distinctlyregulate ER-mediated gene expression.  Steroids75 (12): 870-878, 2010. DOI: 10.1016/j.steroids.2010.05.007

 

Zimmermann, C., Tilghman, S., Boue, S., Salvo, V.A.,Elloitt, S., Williams, K., Skripnikova, E.V., Ashe, H., Payton-Stewart, F.,Vanhoy-Rhodes, L., Fonseca, J.P., Corbitt, C., Collins-Burow, B., Howell, M.,Lacey, M., Shih, B., Carter-Wientjes, C., Cleveland, T., McLachlan, J., Wiese,T., Beckman, B., Burow, M.E.  GlyceollinI, a novel anti-estrogen phytoalexin isolated from activated soy.  J Pharmacol Experimental Therapeutics 332(1): 35-45, 2010. doi: 10.1124/jpet.109.160382

 

Payton-Stewart, F.,Schoene, N., Kim, Y., Burow, M.E., Cleveland, T., Boue, S., and Wang, T.  Molecular effects of soy phytoalexinsglyceollin in human prostate cancer cells, LNCaP.  Molecular Carcinogenesis 48 (9): 862-71,2009.doi: 10.1002/mc.20532

 

Boue, S., Tilghman, S.,Elloitt, S., Zimmerman, C., Williams, KY, Payton-Stewart, F., Miraflor,A., Howell, M., Shih, BY, Carter-Wientjes, CH, Segar, C., Beckman, BS., Wiese,TE., Cleveland, T., McLachlan, J., and Burow, ME.  Identification of the potent phytoestrogenglycinol in elicited soybean (Glycine max). Endocrinology 150 (5): 2446-53, 2008. doi: 10.1210/en.2008-1235

 

Payton, Florastina,Sandusky, Peter, and Alworth, William.  Curcumin:An NMR Study.  Journal of NaturalProducts 70 (2), 143-146, 2007. https://pubs.acs.org/doi/10.1021/np060263s

 

Mague, J.T., Alworth, W.L., Payton, F.L.  Curcumin and derivatives.  Acta Crystallographica 60C:608-610.  2004.

 

LCRC Faculty

Weishan Huang, PhD
Therapeutics & Diagnostics
LSU - School of Veterinary Medicine
Thomas Huckaba PhD
Drug Discovery
Xavier University
Reza Izadpanah, DVM PhD
Tumor Biology
Tulane University School of Medicine
James Jackson PhD
Tumor Biology
Tulane University School of Medicine
Amelia Jernigan MD
Therapeutics & Diagnostics
LSU Health - New Orleans
Jun-yuan Ji PhD
Tumor Biology
Tulane University School of Medicine
Xiang Ji PhD
Population Sciences
Tulane University School of Medicine
Seetharama D Jois PhD
Therapeutics & Diagnostics
University of Louisiana Monroe
Lindsey Keith-Vincent EdD
Tumor Biology
Louisiana Tech University